Rankings
Biotech and biologics
Holders of biotechnological products, blood products, vaccines and cell therapies.
This league table shows the 10 leading companies by number of human medicines authorised by Swissmedic. The source is the official list of authorised products as of 1 September 2026. Multiple strengths of one brand count as a single authorisation.
| Rank | Company | Sector | Canton | Medicines | Share |
|---|---|---|---|---|---|
| 1 | Biomed AG | Biotech | Zurich | 31 | |
| 2 | Amgen Switzerland AG | Biotech | Zug | 28 | |
| 3 | Gilead Sciences Switzerland Sàrl | Biotech | Zug | 24 | |
| 4 | ALK-Abelló AG | Biotech | Zurich | 23 | |
| 5 | CSL Behring AG | Biotech | Bern | 21 | |
| 6 | Stallergenes AG | Biotech | Zurich | 21 | |
| 7 | Octapharma AG | Biotech | Schwyz | 12 | |
| 8 | OM Pharma SA | Biotech | Geneva | 12 | |
| 9 | Biogen Switzerland AG | Biotech | Zug | 11 | |
| 10 | Samsung Bioepis CH GmbH | Biotech | Lucerne | 11 |
Method
We count authorisation numbers for human medicines where the company is recorded as the marketing-authorisation holder. Dosage strengths are not counted separately. Veterinary medicines and medical devices are excluded because Swissmedic keeps them in separate registers.
Frequently asked questions
Who are the largest biotech companies in Switzerland?
This league table shows the 10 leading companies by number of human medicines authorised by Swissmedic. The source is the official list of authorised products as of 1 September 2026. Multiple strengths of one brand count as a single authorisation.
How is this league table calculated?
We count authorisation numbers for human medicines where the company is recorded as the marketing-authorisation holder. Dosage strengths are not counted separately. Veterinary medicines and medical devices are excluded because Swissmedic keeps them in separate registers.
What share of all authorisations does this table cover?
194 authorisations (3 % of 6'770 authorisations).